02 August 2022

GENE DOLGOFF

516-338-5000
Gene@holobeamtech.com
Patent #11,400,306

HOLOGRAPHY PIONEER GRANTED WORLD’S FIRST PATENT
TO TELEPORT ENERGY THROUGH THE BODY TO TREAT CANCER

WESTBURY, NEW YORK (August 2, 2022) – Tech start-up Holobeam Technologies Inc. announced
today that it has been granted a United States patent for a process that can safely send energy waves through the body to detect, diagnose, and treat cancer, arterial plaques, and Covid-like viruses. The nearly instantaneous process will not harm healthy tissue, nor cause unwanted side effects.

 

Holobeam calls its proprietary process, Holographic Energy Teleportation (HET).
The announcement was made by Gene Dolgoff, Holobeam’s founder, CEO, Chief Technology Officer, and holder of over 65 worldwide patents. He has been making holograms since 1964, making him one of the world’s earliest holographers.

 

Since 1963, holography has been a novel method of producing completely accurate, 3-D images, using lasers. Dolgoff, however, believes he’s found a way to harness the science behind holography to achieve what has only ever been the stuff of science fiction: to precisely place energy in any desired spatial location via “teleportation.”
 

“It’s science fiction come to life,” Dolgoff said. “HET will enable us to send energy from Point A precisely to Point C, without any energy passing through Points B, in between, or Points D, beyond.
 

“We’ve known for thousands of years that heat kills pathogens. But if not precisely controlled, heat-producing energy waves can damage healthy tissue. HET provides that precision and control, eliminating the potential danger, while producing a successful outcome.”
 

In medical applications, Dolgoff explained, the HET process sends a beam of laser-generated energy through the body to detect, diagnose, and obliterate diseased cells. Given that HET cancels out these energy waves as they pass through and beyond healthy tissue, only diseased cells are impacted.
 

Dolgoff added that HET will detect pathogens far earlier than is possible with conventional MRI and CT scanning devices. “Early detection,” he said, “is a key to achieving successful outcomes.”
 

Dolgoff also explained that beyond the medical space, HET could apply to other industries searching
for clean, abundant, and sustainable energy. “For example,” he pointed out, “we’re already exploring options with interested parties in green, renewable, solar-powered energy generation and distribution.”

 

Holobeam plans to begin product development as soon as the company completes its initial funding goals.

Holobeam Technologies
HET Patent Announcement Release
08.02.2022
v4c